Gregory R. Bebernitz

The Effect of 1,3-Diaryl-[1H]-pyrazole-4-acetamides on Glucose Utilization in ob/ob Mice

Gregory R. Bebernitz, Greg Argentieri, Beverly Battle et al. · Journal of Medicinal Chemistry · 2001 · 140 citations

Glucose Transport, Metabolic Syndrome, Medicinal Chemistry +15

Investigation of Functionally Liver Selective Glucokinase Activators for the Treatment of Type 2 Diabetes

Gregory R. Bebernitz, Valérie Beaulieu, Bethany A. Dale et al. · Journal of Medicinal Chemistry · 2009 · 91 citations

Gk Enzyme, Glycobiology, Pharmaceutical Chemistry +18

Total synthesis of (-)-tirandamycin A

R. H. Schlessinger, Gregory R. Bebernitz, Peter Lin et al. · Journal of the American Chemical Society · 1985 · 83 citations

Medicinal Chemistry, Biosynthesis, Molecular Sciences +15

Anilides of (<i>R</i>)-Trifluoro-2-hydroxy-2-methylpropionic Acid as Inhibitors of Pyruvate Dehydrogenase Kinase

Gregory R. Bebernitz, Thomas D. Aicher, James L. Stanton et al. · Journal of Medicinal Chemistry · 2000 · 60 citations · Full text

Pharmaceutical Science, Oral Bioavailability, Lactate Levels +17

(<i>R</i>)-3,3,3-Trifluoro-2-hydroxy-2-methylpropionamides Are Orally Active Inhibitors of Pyruvate Dehydrogenase Kinase

Thomas D. Aicher, Robert C. Anderson, Gregory R. Bebernitz et al. · Journal of Medicinal Chemistry · 1999 · 43 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Molecular Sciences +14